Revenues From Sedar filings:
_______________9mo _____________Q3
Revenue 3,646,000 1,426,000
Fees 1,223,000 1,223,000
SubTotal 4,869,000 2,649,000
________________Q2 _____________Q1
Revenue 1,430,000 790,000
Fees 0 0
-----------------------------------
Compared to
YE 2003
Revenue 950,000
Fees 0
Breakdown of YE 2003
Pennsaid 433,000
Oxo Prod 316,000
sub total 749,000
other 201,000
--------------------------------------------------
Geographic Break down - Fiscal 2004
______________Q3 ___________Q2 ___________Q1
Canada 2,194,000 1,075,000 656,000
Europe 327,000 263,000 95,000
Other 128,000 92,000 39,000
Total 2,649,000 1,430,000 790,000 |
